ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,15
-0,79%
Dow Jones
40 211,72
0,00%
DAX
18 492,06
-0,58%
Brent Oil
83,055
-1,52%
Bitcoin
64 146,91
-1,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/07/201513h51Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201512h42PR Newswire (US)Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201512h30Dow Jones NewsTeva to Buy Allergan Generics for $40.5 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201512h28Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/07/201512h03Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/07/201510h47Business WireTeva Reports Preliminary Second Quarter 2015 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201510h31Business WireTeva Withdraws Proposal to Acquire MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201510h30Business WireTeva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics & Specialty Company Well Positioned to...NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201503h52Dow Jones NewsTeva Poised to Get a Big Boost in GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201503h10Dow Jones NewsAllergan to Acquire Naurex for $560 Million CashNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/07/201501h51Dow Jones NewsHealth Care's Deal FeverNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/201503h13Dow Jones NewsTeva in Talks to Buy Allergan's Generics Unit -- 4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/201501h55Dow Jones NewsTeva in Talks to Buy Allergan's Generic Unit -- 3nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
26/07/201501h01Dow Jones NewsTeva in Talks to Buy Allergan's Generic Unit -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
26/07/201500h52Dow Jones NewsTeva in Talks to Buy Allergan's Generic Unit -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
24/07/201515h00PR Newswire (US)Technical Report on Drug Manufacturers - Other Stocks -- Synergy Pharma, Teva Pharma, Orexigen Therapeutics, Prana Biotechnol...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/07/201518h20Dow Jones NewsDrugmaker Mylan Uses Dutch Foundation to Fend Off Hostile BidNYSE:TEVATeva Pharmaceutical Industries Ltd
23/07/201515h02Business WireTeva Issues StatementNYSE:TEVATeva Pharmaceutical Industries Ltd
23/07/201515h00Business WireTeva Launches Educational Initiative to Arm Women with Facts about Emergency ContraceptionNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201516h18Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201516h00Business WireTeva to Report Second Quarter 2015 Financial Results on July 30, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
08/07/201519h47Business WireTeva First to Receive Approval and Launch Generic Axert® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/07/201519h06Dow Jones NewsTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -BloombergNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201514h30Business WireTeva Launches Generic Aggrenox® Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201514h00Business WireTeva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis PainNYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201517h03The Motley FoolThe Biotech Drug Lord: How One Man Is Conquering The Biotech SpaceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/06/201514h00Business WireTeva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/201514h00Business WireTeva Launches PainMatters.com to Support Responsible Pain ManagementNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201515h30Dow Jones NewsTeva Takes 4.6% Stake in MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201514h30Business WireTeva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

LSE
NDIA
Ish India Usd A
LSE
MKUW
Ivz Msci Kuwait
NYSE
LEO
BNY Mellon Strategic Mun...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés